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blood pressure control for patients in general 
practice: The CoCo trial
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Abstract
Background: Insufficient blood pressure control is a frequent problem despite the existence of effective treatment. 
Insufficient adherence to self-monitoring as well as to therapy is a common reason. Blood pressure self-measurement 
at home (Home Blood Pressure Measurement, HBPM) has positive effects on treatment adherence and is helpful in 
achieving the target blood pressure. Only a few studies have investigated whether adherence to HBPM can be 
improved through simple measures resulting also in better blood pressure control.
Objective: Improvement of self-monitoring and improved blood pressure control by using a new colour-coded blood 
pressure diary.
Outcome: Primary outcome: Change in systolic and/or diastolic blood pressure 6 months after using the new colour-
coded blood pressure diary.
Secondary outcome: Adherence to blood pressure self-measurement (number of measurements/entries).
Methods/Design: Randomised controlled study.
Population: 138 adult patients in primary care with uncontrolled hypertension despite therapy. The control group
uses a conventional blood pressure diary; the intervention group uses the new colour-coded blood pressure diary
(green, yellow, red according a traffic light system).
Expected results/conclusion: The visual separation and entries in three colour-coded areas reflecting risk (green: 
blood pressure in the target range ≤ 140/≤ 90 mmHg, yellow: blood pressure >140/>90 mmHg, red: blood pressure in 
danger zone > 180 mmHg/>110 mmHg) lead to better self-monitoring compared with the conventional (non-colour-
coded) blood pressure booklet. The colour-coded, visualised information supports improved perception (awareness 
and interpretation) of blood pressure and triggers correct behaviour, in the means of improved adherence to the 
recommended treatment as well as better communication between patients and doctors resulting in improved blood 
pressure control.
Trial registration: ClinicalTrials.gov ID NCT01013467
Background
Arterial hypertension is the most common cardiovascu-
lar risk factor throughout the world and guidelines for the
management of hypertension underscore the need for
strict blood pressure (BP) control to decrease the risk of
morbidity and mortality in hypertensive patients [1,2].
Despite the available evidence that even mild hyperten-
sion is linked to a considerably higher cardiovascular risk,
many patients do not reach the target blood pressure
under treatment [3].
In Switzerland every seventh adult is affected, only half
of them receive treatment. Of those patients treated,
which cost the health system in Switzerland over CHF
435 million in 2005 [4], only one-eighth [5] reaches
appropriate blood pressure control.
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agement of hypertension is patient adherence to treat-
ment [6]. A plethora of data exists regarding adherence in
the treatment of hypertension [7-12].
A review on how to reach targets in the treatment of
diabetes patients in primary care showed that interven-
tions with the greatest positive effect were complex and
should include activities which change the behaviour of
doctors, changes to practice organisation, expansion and
provision of information and educational programmes
for patients [13]. The measures to promote adherence in
such programmes are the combination of patient infor-
mation, promoting and supporting self-monitoring sup-
port through regular monitoring and inquiries by
telephone, social support as well as treatment plans tai-
lored to the individual [14]. Most of these measures
require time and personal effort for training and follow-
up, which is not easy to implement in the everyday prac-
tice life.
With a chronic illness as hypertension the role of the
patient changes. The patient is central to efforts to moni-
tor and control the illness to the best possible extent.
Knowledge about illness and treatment is the basis, but in
particular behaviour strategies are necessary to achieve
the best possible long-term control. Our study focuses on
patient-related factors as the central condition for
improved treatment adherence [15].
Blood-pressure self-measurement at home (HBPM) is
an established and evidence-based behaviour measure,
which is recommended in guidelines on the treatment of
hypertension and which has been shown to improve
knowledge about treatment and also adherence to treat-
ment with medication by about 20% [16-19]. Until now
only few studies investigated the use of a simple practice
tool in hypertensive patients to improve self-monitoring
and adherence to HBPM considering its possible effect
on blood pressure. We therefore aim to investigate the
effect of a colour coded blood pressure diary following a
traffic light system (green, yellow, red) on adherence to
self-measurement and blood pressure monitoring.
Hypothesis
The colour-coded blood pressure booklet improves
adherence to self-monitoring (higher number of HBPM)
and leads to improved blood pressure control.
We are assuming that the colour-coded tool supports
adequate patient behaviours by improving awareness and
interpretation of blood pressure control. It also might
support better patient-doctor communication which is a
central aspect for treatment adherence and improved
blood pressure control.
Methods/design
A two-armed study randomised and controlled at patient
level. The intervention group will receive a new colour-
coded blood pressure booklet, the control group a stan-
dard blood pressure record booklet without colour cod-
ing. The measuring period for both groups is 6 months
(figure 1).
Inclusion criteria for general practitioners
General practitioners will be invited to join the study via
letters sent by post and information sessions. Any general
practitioners who provide basic medial care with a work-
load of at least 20 hours per week are entitled to partici-
pate in the study.
Inclusion criteria for patients
• Age >18 years
• BP > 140/90 mmHg
Two consecutive measurements carried out in the
practice
(measured by the general practitioner or practice
assistant at the start of the study; both measurements
must be greater that 140/90 mmHg with the second
measurement qualifying for inclusion.
• Unchanged anti-hypertension treatment for one
month before inclusion
• Patient able to measure blood pressure at home
• Written informed consent
Exclusion criteria
• Blood pressure reading over 180 mmHg systolic
and/or 110 mmHg diastolic.
• Serious general or psychological illness (malignant
tumours, serious depressive episodes or evidence of
dementia).
• Insufficient knowledge of the German language for
instruction and blood pressure recording with a
booklet.
All patients will be asked consecutively about partici-
pating in the study and they will be handed an informa-
tion sheet. All patients who have been approached will be
included in a list containing the blood pressure booklet
code which will be passed on to the study centre. The list
remains in the practice so that the study leaders only have
anonymous access to the patient data. However, in the
practice it is possible to link the blood pressure record
book with the medical file of the patient so that all the
clinical data is available. Any patients who have been
approached and have declined to participate will be
included in a list in order to carry out a non-responder
analysis of patients with regard to socio-demographic and
clinical data.
Sample Size
Case number calculation and power analysis were carried
out on the basis of the expected effect for systolic blood
pressure. With an alpha of 0.05 and a power of 0.9 (one-
sided test) this means that 138 patients are required in
order to be able to show a clinically relevant blood pres-
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ation of 14 mmHg between the groups. Assuming a
dropout rate of 20% this means that at least 166 patients
are required.
Randomisation
The randomisation (colour-coded vs. conventional blood
pressure booklet) will take place at patient-level and will
be carried out centrally by the study centre. We will draw
up a randomising list by computer (ralloc command of
Stata software for Windows, Version 9). The blood pres-
sure record booklets will be distributed on the basis of
this list in consecutively numbered opaque envelopes.
The opaque envelopes will be given to the practices in
numerical order. They can not be resealed. GPs are asked
to notice the number (code) of the booklet (colour-coded
or normal) on a list together with the name and birthday
of the patient and generate a code out of this data. This
list will remain in the practice and is just for the purpose
to be able to link the booklets with the patients name and
therefore the patients' medical file. The study centre will
receive a list with the generated code of the patient and
the distributed booklet. So, the linkage to the name and
medical file is only possible with the list held by the GP.
Opened but not used envelopes have to be noticed in the
list as used ones and marked as "not distributed". The
practices will each receive four envelopes in which there
will either be a colour-coded or a standard record book-
let. The patients will be included consecutively and the
doctor will open one envelope after the other in the order
of the envelope numbers. In practice number one enve-
lopes 1-4 will be opened consecutively, in practice num-
ber two envelopes 5-8 etc. This central randomisation
means that the concealment of random allocation is
ensured.
Figure 1 Study flow chart.
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Blinding of the general practitioners regarding group
identity is not possible. Patients do only know that differ-
ent types of blood pressure record booklets are being dis-
tributed, but they do not know in detail what the
difference between the booklets is.
Intervention
The patients in the intervention group will receive a
colour-coded blood pressure record booklet. The corre-
sponding colour coded areas are divided into three areas
of green, yellow and red following a traffic light system.
The green area covers blood pressure readings up to a
maximum of 140/90 mmHg, the yellow area includes sys-
tolic readings over 140 to 180 mmHg and diastolic read-
ings over 90 to10 mmHg. The red area covers systolic
readings over 180 mmHg and diastolic readings over 110
mmHg. All patients will be trained in the standardised
use of the blood pressure record booklet including home
blood pressure measurement additional they receive an
instruction leaflet. They will be asked to measure their
blood pressure in the morning while they are sitting and
before they take their blood pressure medicaments. The
readings will be recorded in the relevant blood pressure
booklet for six months. All patients will be trained in the
same way for one of the two study BP booklets by the
general practitioner or the practice assistant for the dura-
tion of the study. The general practitioners and practice
assistants will receive the same instruction and training
for this as well as an instruction leaflet. Validated elec-
tronically blood pressure meters (MioStar Cardioplus
500) will be provided to all practices and patients to
assure a standardization of the measurement. All mea-
surements have to be performed with these meters.
Data collection
Primary end point
There will be blood pressure measurements by the gen-
eral practitioner at the start (t0) as well as after 3 months
(t1) and at the end of the study after 6 months (t2). To
rule out blood pressure differences BP will be measured
at both arms at t0. Each subsequent measurement in the
practice of the general practitioner will involve two blood
pressure measurements in each case in the left arm if the
initial measurement did not differ between both arms by
more than 5 mm Hg. If the measurement differed by
more than 5 mm Hg at t0, BP will be measured at the arm
with the higher reading subsequently. All the readings
will be recorded, but for inclusion (as stated above) as ell
as for analysis, the second measurement will be used. The
difference (t2-t0) between the systolic blood pressure
readings at the practice measurement represents the pri-
mary end point.
All patient contacts will be collected over the entire
period. At time t2 (after the end of the study) the number
of times there was contact with the general practitioner
since the inclusion of the patient will be recorded.
Secondary end point
- Number of patients, who achieve blood pressure control
under 140/90 mm Hg.
- Adherence: the absolute number of blood pressure
measurements (entries in the BP record booklet) by the
patients will be assessed as correlative of adherence dur-
ing the period of observation.
The first supply of data takes place at randomisation
and subsequent at the specific measuring points t1 and
t2.
Analysis
At the end of the study the list with the booklet codes as
well as the code, generated out of the patients' name and
his birthday will be send to the study centre. In the study
centre, all received questionnaires and lists will be
scanned electronically and a TIF-file will be generated to
avoid data manipulation. The data will be directly
exported in the statistic program (STATA, version 9).
Descriptive statistics: average value with +/- 1 SD and
median values of the average blood pressure readings for
both groups. In accordance with the normal distribution
test it will be decided whether parametric or non-para-
metric tests are to be applied. Treatment group compari-
sons for categorical data will be done with the χ2 test. For
continuous variables, comparisons between treatment
groups were done with t tests.
Primary outcome: difference (t2-t0) between the sys-
tolic blood pressure average readings from the practice
measurement. All patients will be analysed in accordance
with the „intention-to-treat” approach and the latest
available measurement will be used (last- observation
carried forward). When interventions are provided via
GPs, one should be aware of a cluster effect. We decided
to perform a randomisation on the patient's level since
the effect mediated by the GP on the intervention is
assumed to be small. Nevertheless, we will account for
that and include the factor "Practice" as a random effect
in the analysis.
Discussion
Although there is a large amount of data on non adher-
ence in chronic illnesses such as diabetes, heart failure,
chronic lung disease and hypertension, there is relatively
little research data on interventions which try to solve the
problem of non-adherence. In addition, the conclusions
of intervention studies are often based on subjective
patient information and not on objective investigations.
Data and evidence on a true change in behaviour assessed
with hard clinical end points are needed.
Our study measures the use of a simple, practicable
intervention tool. A new BP record booklet containing
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blood pressure control that is useful as feedback for the
patient and doctor and can help to improve patient-doc-
tor communication as well as triggering appropriate
behaviour strategies. A change or adjustment in behav-
iours is an important precondition to achieve relevant
clinical end points in the case of chronic illnesses
(improvement of adherence, reaching treatment targets,
reduction in complications and secondary failures as well
as lowering direct and indirect costs).
If there is evidence of a significant effect with this sim-
ple intervention and the new hypertension control tool,
then this benefit can be achieved without additional
treatment and risk of side-effects, without relevant addi-
tional costs and without additional effort for the patient
and doctor. Patients, who measure their blood pressure at
home generally, record their blood pressure. The docu-
mentation in a different record booklet as used previously
therefore means no extra effort. The instruction for using
the new blood pressure record booklet is also no extra
effort for the "health professionals", in this case the gen-
eral practitioner or practice assistant. No extra work load
is an important condition for implementation of evidence
based recommendations into practice.
Limitations of the study
A double blind approach is not possible because training
has to be given on the blood pressure record booklet.
Some sub-groups (age stratification, gender, education)
are too small to reach significance.
Ethical principles
The study is being conducted in accordance with medical
professional codex and the Helsinki Declaration as of
1996 as well as Data Security Laws.
Study participation of patients is voluntary and can be
cancelled at any time without provision of reasons and
without negative consequences for their future medical
care.
Patient informed consent
Previous to study participation patients receive written
and spoken information about the content and extent of
the planned study; for instance about potential benefits
for their health and potential risks. In case of acceptance
they sign the informed consent form.
In case of study discontinuation all material will be
destroyed or the patient will be asked if he/she accepts
that existing material can be analyzed in the study.
Vote of the ethics committee
The study protocol is approved by the ethics committee
of Zurich (Kantonale Ethikkommission (KEK) Zürich
(EK-1738).
Data security/disclosure of original documents
The patient names and all other confidential information
fall under medical confidentiality rules and are treated
according to appropriate Federal Data Security Laws. All
study related data and documents are stored on a pro-
tected central server of the University of Zurich. Only
direct members of the internal study team can access the
respective files.
Intermediate and final reports are stored at the Depart-
ment of General Practice at the Zurich University Hospi-
tal (USZ).
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